UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Breast cancer research : BCR, 2020-10, Vol.22 (1), p.114-114, Article 114

2020

Volltextzugriff (PDF)

Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC

Japanese journal of clinical oncology, 2022-11, Vol.52 (11), p.1265-1269

2022

Volltextzugriff (PDF)

Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients

Supportive care in cancer, 2021-10, Vol.29 (10), p.6119-6125

2021

Volltextzugriff (PDF)

Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1287-1293

2010

Volltextzugriff (PDF)

Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”

Breast cancer (Tokyo, Japan), 2023-11, Vol.30 (6), p.1106-1106

Ohsumi, Shozo

2023

Volltextzugriff (PDF)

Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy

Supportive care in cancer, 2021, Vol.29 (1), p.437-443

2021

Volltextzugriff (PDF)

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study

British journal of cancer, 2020-06, Vol.122 (12), p.1747-1753

2020

Volltextzugriff (PDF)

Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer

Acta medica Okayama, 2022-04, Vol.76 (2), p.105-111

2022

Volltextzugriff (PDF)

Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling

Acta medica Okayama, 2022-12, Vol.76 (6), p.673-678

2022

Volltextzugriff (PDF)

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review

BMC cancer, 2018-05, Vol.18 (1), p.576-576, Article 576

2018

Volltextzugriff (PDF)

Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

BMC cancer, 2021-10, Vol.21 (1), p.1-1077, Article 1077

2021

Volltextzugriff (PDF)

Present issues regarding BRCA genetic testing and genetic counseling in medical care for HBOC patients in Japan

Annals of oncology, 2019-10, Vol.30, p.vi52

Ohsumi, Shozo

2019

Volltextzugriff (PDF)

PD6-4Present issues regarding BRCA genetic testing and genetic counseling in medical care for HBOC patients in Japan

Annals of oncology, 2019-10, Vol.30 (Supplement_6)

Ohsumi, Shozo

2019

Volltextzugriff (PDF)

Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection

Breast cancer (Tokyo, Japan), 2020-03, Vol.27 (2), p.284-290

2020

Volltextzugriff (PDF)

Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients

International journal of clinical oncology, 2019-03, Vol.24 (3), p.274-287

2019

Volltextzugriff (PDF)

Risk factors of impairment of shoulder function after axillary dissection for breast cancer

Supportive care in cancer, 2021-02, Vol.29 (2), p.771-778

2021

Volltextzugriff (PDF)

Four magnetic resonance imaging surveillance-detected breast cancer cases in cancer-free BRCA1/2 mutation carriers

Surgical case reports, 2021-10, Vol.7 (1), p.228-228, Article 228

2021

Volltextzugriff (PDF)

Influence of and Risk Factors for Axillary Web Syndrome Following Surgery for Breast Cancer

Acta medica Okayama, 2021-02, Vol.75 (1), p.39-44

2021

Volltextzugriff (PDF)

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab -paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)

Japanese journal of clinical oncology, 2022-10, Vol.52 (10), p.1124-1133

2022

Volltextzugriff (PDF)

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery

Breast cancer research and treatment, 2011-08, Vol.128 (3), p.735-747

2011

Volltextzugriff (PDF)

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

Breast cancer research and treatment, 2021-02, Vol.186 (1), p.135-147

2021

Volltextzugriff (PDF)

Characteristics of Postoperative Patients with Breast Cancer Aged 65 Years and Older

Current oncology (Toronto), 2023-01, Vol.30 (1), p.673-680

2023

Volltextzugriff (PDF)

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

BMC cancer, 2017-11, Vol.17 (1), p.773-773, Article 773

2017

Volltextzugriff (PDF)

Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study

Clinical and experimental medicine, 2023-12, Vol.23 (8), p.5129-5138

2023

Volltextzugriff (PDF)

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy

Breast cancer (Tokyo, Japan), 2023-01, Vol.30 (1), p.131-138

2023

Volltextzugriff (PDF)

1 – 25 von 194

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(175)
Mit Volltextzugriff
(173)

Publikationsform

Artikel
(192)
Berichte
(2)

Sprache

Englisch
(184)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT study

Risk-reducing mastectomy for women with hereditary breast and ovarian cancer (HBOC): analytical results of data from the Japanese Organization of HBOC

Prospective study of hair recovery after (neo)adjuvant chemotherapy with scalp cooling in Japanese breast cancer patients

Significant Effect of Polymorphisms in CYP2D6 and ABCC2 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

Reply to “Is venous thromboembolism a time-dependent event in breast cancer patients taking tamoxifen?”

Scalp cooling for hair loss prevention in female Japanese breast cancer patients receiving (neo)adjuvant chemotherapy

Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study

Pathological Complete Response Patients after Neoadjuvant Chemotherapy in Breast Cancer

Handling of Germline Findings in Clinical Comprehensive Cancer Genomic Profiling

Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review

Multicenter retrospective study on the use of Curebest™ 95GC Breast for estrogen receptor-positive and node-negative early breast cancer

Present issues regarding BRCA genetic testing and genetic counseling in medical care for HBOC patients in Japan

PD6-4Present issues regarding BRCA genetic testing and genetic counseling in medical care for HBOC patients in Japan

Risk factors for early postoperative psychological problems in breast cancer patients after axillary lymph node dissection

Palbociclib in combination with letrozole in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients

Risk factors of impairment of shoulder function after axillary dissection for breast cancer

Four magnetic resonance imaging surveillance-detected breast cancer cases in cancer-free BRCA1/2 mutation carriers

Influence of and Risk Factors for Axillary Web Syndrome Following Surgery for Breast Cancer

Subgroup analysis of Japanese patients in a phase III randomized, controlled study of neoadjuvant atezolizumab or placebo, combined with nab -paclitaxel and anthracycline-based chemotherapy in early triple-negative breast cancer (IMpassion031)

Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery

Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)

Characteristics of Postoperative Patients with Breast Cancer Aged 65 Years and Older

Cost-effectiveness analysis of the introduction of S-1 therapy for first-line metastatic breast cancer treatment in Japan: results from the randomized phase III SELECT BC trial

Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study

A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy

Suchergebnisse filtern